linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company Background  
Ajanta Pharma Ltd.
 
Industry : Pharmaceuticals & Drugs House : Vimal Agrawal
BSE Code 532331
ISIN Demat INE031B01049
Book Value 350.00
NSE Code AJANTPHARM
Dividend Yield % 0.97
Market Cap 362425.75
P/E 38.28
EPS 75.78
Face Value 2  
 
Incorporation Year 31-12 1979  
Registered Office Ajanta Tower, 54 - A,M V Road, Chakala,Andheri (East), Mumbai,
Maharashtra-400093 .
ISINNO INE031B01049  
Phone 022-60609000 / 66061000  
E-mail legal.info@ajantapharma.com
URL www.ajantapharma.com
Industry Pharmaceuticals & Drugs  
Chairman Mannalal B Agrawal  
Managing Director Yogesh M Agrawal  
Company Secretary Gaurang Shah  
Listing BSE,NSE  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.